newsfilter
← Latest News
Business Wire·

AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results

Signed research collaboration with University of California, Irvine, on research program for exosome-based therapies for certain brain disorders Licensee ImStem Biotechnology announced first U.S. multiple sclerosis patient dosed with IMS001